Novavax (NASDAQ:NVAX) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $(0.52) by 121.15 percent. This is a 121.57 percent increase over losses of $(0.51) per share from the same period last year. The company reported quarterly sales of $147.139 million which beat the analyst consensus estimate of $78.838 million by 86.63 percent. This is a 66.61 percent increase over sales of $88.311 million the same period last year.